149 related articles for article (PubMed ID: 9324998)
41. Progress with inactivated poliovirus vaccines derived from the Sabin strains.
Doi Y; Abe S; Yamamoto H; Horie H; Ohyama H; Satoh K; Tano Y; Ota Y; Miyazawa M; Wakabayashi K; Hashizume S
Dev Biol (Basel); 2001; 105():163-9. PubMed ID: 11763324
[TBL] [Abstract][Full Text] [Related]
42. Monoclonal antibodies specific for the Sabin vaccine strain of poliovirus 3.
Ferguson M; Yi-hua Q; Minor PD; Magrath DI; Spitz M; Schild GC
Lancet; 1982 Jul; 2(8290):122-4. PubMed ID: 6123838
[TBL] [Abstract][Full Text] [Related]
43. Antibody responses against avian reovirus nonstructural protein sigmaNS in experimentally virus-infected chickens monitored by a monoclonal antibody capture enzyme-linked immunosorbent assay.
Chen PN; Liu HJ; Shien JH; Lee LH
Res Vet Sci; 2004 Jun; 76(3):219-25. PubMed ID: 15046956
[TBL] [Abstract][Full Text] [Related]
44. [Thermostability and immunogenicity of trivalent oral poliovirus vaccine produced by different countries].
Kong J
Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Jun; 14(3):151-4. PubMed ID: 8221837
[TBL] [Abstract][Full Text] [Related]
45. A monoclonal antibody-based competitive enzyme-linked immunosorbent assay for detecting antibody production against avian reovirus protein sigmaA.
Lin YL; Shen JH; Lee LH
J Virol Methods; 2006 Sep; 136(1-2):71-7. PubMed ID: 16730382
[TBL] [Abstract][Full Text] [Related]
46. Antigenic structure of poliovirus in inactivated vaccines.
Ferguson M; Wood DJ; Minor PD
J Gen Virol; 1993 Apr; 74 ( Pt 4)():685-90. PubMed ID: 7682250
[TBL] [Abstract][Full Text] [Related]
47. Determination of type 1 poliovirus subtype classes with neutralizing monoclonal antibodies.
Crainic R; Couillin P; Cabau N; Boue A; Horodniceanu F
Dev Biol Stand; 1981; 50():229-34. PubMed ID: 6176486
[TBL] [Abstract][Full Text] [Related]
48. Localization and fine mapping of antigenic sites on the nucleocapsid protein N of porcine reproductive and respiratory syndrome virus with monoclonal antibodies.
Meulenberg JJ; van Nieuwstadt AP; van Essen-Zandbergen A; Bos-de Ruijter JN; Langeveld JP; Meloen RH
Virology; 1998 Dec; 252(1):106-14. PubMed ID: 9875321
[TBL] [Abstract][Full Text] [Related]
49. [Determination of the virus content in oral trivalent candy poliovaccine using monoclonal antibodies to poliovirus].
Chen SF; Jiang SD; Guan ZD
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1986 Feb; 8(1):72-3. PubMed ID: 3017590
[No Abstract] [Full Text] [Related]
50. Human monoclonal antibodies that neutralize vaccine and wild-type poliovirus strains.
Puligedda RD; Kouiavskaia D; Adekar SP; Sharma R; Devi Kattala C; Rezapkin G; Bidzhieva B; Dessain SK; Chumakov K
Antiviral Res; 2014 Aug; 108():36-43. PubMed ID: 24824031
[TBL] [Abstract][Full Text] [Related]
51. Potency test of killed polio vaccines. Statistical analysis of test on chicken and preliminary results in combination with ELISA D-antigen determinations.
Larbaigt G; Moulin J; Souvras M; Gibelin N; Beranger G
Dev Biol Stand; 1981; 47():113-8. PubMed ID: 6262141
[TBL] [Abstract][Full Text] [Related]
52. Poliovirus vaccine strains detected in stool specimens of immunodeficient children in South Africa.
Pavlov DN; Van Zyl WB; Kruger M; Blignaut L; Grabow WO; Ehlers MM
Diagn Microbiol Infect Dis; 2006 Jan; 54(1):23-30. PubMed ID: 16290028
[TBL] [Abstract][Full Text] [Related]
53. VaxArray immunoassay for the multiplexed quantification of poliovirus D-antigen.
Dawson ED; Taylor AW; Johnson JE; Hu T; McCormick C; Thomas KN; Gao RY; Wahid R; Mahmood K; Rowlen KL
J Immunol Methods; 2022 May; 504():113259. PubMed ID: 35314144
[TBL] [Abstract][Full Text] [Related]
54. [Evaluation of an ELISA kit made in our laboratory for intratypic discrimination of poliovirus type 1 strains isolated from acute flask paralysis].
Ozkaya E; Arita M
Mikrobiyol Bul; 2002 Jan; 36(1):71-7. PubMed ID: 12476769
[TBL] [Abstract][Full Text] [Related]
55. Antigenic potency of inactivated poliovirus vaccines.
Moynihan M; Petersen I
Dev Biol Stand; 1981; 47():129-33. PubMed ID: 6262143
[TBL] [Abstract][Full Text] [Related]
56. Laboratory tests for live attenuated poliovirus vaccines.
Wood DJ; Macadam AJ
Biologicals; 1997 Mar; 25(1):3-15. PubMed ID: 9167004
[TBL] [Abstract][Full Text] [Related]
57. Potency testing of inactivated tissue culture vaccine against Japanese encephalitis using antigen capture ELISA.
Joshi AM; Walimbe AM; Banerjee K
Acta Virol; 1997 Jun; 41(3):157-9. PubMed ID: 9385404
[TBL] [Abstract][Full Text] [Related]
58. Intestinal trypsin can significantly modify antigenic properties of polioviruses: implications for the use of inactivated poliovirus vaccine.
Roivainen M; Hovi T
J Virol; 1987 Dec; 61(12):3749-53. PubMed ID: 2824812
[TBL] [Abstract][Full Text] [Related]
59. A comparative study of reactogenicity and immunogenicity of an oral and an inactivated polio vaccine.
Borcić B; Dobrovsak-Sourek V; Kaić B; Ljubicić M
Acta Med Croatica; 1998; 52(3):155-8. PubMed ID: 9818437
[TBL] [Abstract][Full Text] [Related]
60. Analysis of reversions in the 5'-untranslated region of attenuated poliovirus after sequential administration of inactivated and oral poliovirus vaccines.
Laassri M; Lottenbach K; Belshe R; Rennels M; Plotkin S; Chumakov K
J Infect Dis; 2006 May; 193(10):1344-9. PubMed ID: 16619180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
